Timothy M. Wilson
Associate Manager of Business Development and Marketing @Singota Solutions
Signup · Get unlimited contacts
WORK HISTORY
Associate Manager of Business Development and Marketing @Singota Solutions
Promoted to lead the BD & Marketing function, with direct oversight of staff development, departmental strategy, budget management, and senior leadership reporting. Currently manages a team of two with an active search underway to expand the marketing function— Developed and execute a multi-year revenue forecast integrating existing contract commitments, active prospect pipeline, deal probability weighting, and forward-looking market indicators— Established annual budgets and resource plans for BD and Marketing; developed and evaluated corporate marketing strategy in collaboration with senior leadership— Provided direct reporting to senior leadership on pipeline health, forecast accuracy, and marketing campaign performance— Applied market research and competitive analysis to identify opportunities across new client segments, modalities, and emerging regulatory and technology trends— Represent the organization at industry conferences, trade shows, and stakeholder engagement events; built and maintain relationships with key opinion leaders across the injectable CDMO space— Partnered with Project Management and Client Services to ensure seamless transition from deal closure to operational execution.
EDUCATION
North Dakota State University
Doctor of Philosophy - PhD, Biochemistry
North Dakota State University
BS, Biochemistry and Molecular Biology
ABOUT TIMOTHY M. WILSON
Biochemist by training. Operational and commercial leader by practice. PhD in Biochemistry with 15+ years of progressive experience spanning academic research, GMP quality control, analytical development, and business development in the life sciences CDMO sector. In industry, the focus has been on building things that don\'t yet exist: GMP QC departments, analytical infrastructure, laboratory capital programs, and BD pipelines. At Forge Biologics and AmplifyBio, QC and analytical organizations were built from the ground up at startup CGT CDMOs, supporting AAV and cell therapy programs through IND and toward manufacturing readiness. Laboratory capital programs across both sites exceeded $10M. In a current BD leadership role at an aqueous injectable CDMO, the function has produced significant new business growth in 2026. The scientific foundation, including deep fluency in analytical method development, GxP regulatory frameworks, and CGT modalities, translates directly into more effective client conversations. The ability to engage a client\'s scientific leadership as a peer, then transition to scoping, proposal authorship, and deal closure, is a combination that\'s genuinely uncommon in BD. Areas of depth: Viral Vector & Cell therapies · Aqueous injectables · Analytical method development & validation · GMP QC operations · IND/BLA CMC support · BD pipeline development · LIMS/ELN implementation · FDA, ICH & EMA compliance
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.